4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
TG Therapeutics, Inc. (TGTX) operates in the Biotechnology industry and is headquartered in Morrisville, United States with about 399 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, TGTX reported $616M in revenue and $447M in net income.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
Interactive charts & full statements → Open the TGTX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $616M | $329M | $234M | $3M | — |
| Gross Profit | $516M | $290M | $220M | $2M | — |
| Operating Income (EBIT) | $123M | $42M | $21M | ($218M) | — |
| Net Income | $447M | $23M | $13M | ($224M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $205M | $193M | $162M | $141M | $121M |
| Gross Profit | $171M | $154M | $134M | $122M | $105M |
| Operating Income (EBIT) | $35M | $50M | $29M | $35M | $9M |
| Net Income | $20M | $23M | $391M | $28M | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | — | — | — | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.1B | $578M | $330M | $194M | — |
| Total Liabilities | $415M | $355M | $169M | $135M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TGTX viewer.
About TickerBase · Data methodology & sources